Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – Treatment with the antianginal drug ranolazine before elective percutaneous coronary intervention (PCI) significantly reduced procedure-related myocardial injury in a small pilot study from…
NEW YORK (Reuters Health) – Compared with unfractionated heparin (UFH) monotherapy, bivalirudin use in patients undergoing percutaneous coronary intervention via the femoral artery is associated with significantly decreased…
NEW YORK (Reuters Health) – Results of a new meta-analysis indicate that all drug-eluting stents (DES) outperform bare metal stents (BMS) over both the short and long term,…
NEW YORK (Reuters Health) – Using local anesthesia and fluoroscopic guidance is a simplified and effective means of transfemoral aortic valve replacement (TAVR), using the SAPIEN or newer…
NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in…
NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April…
NEW YORK (Reuters Health) – Health-related quality of life (HRQOL) improves in the year after transcatheter aortic valve implantation (TAVI), researchers from UK and Germany find in 2…
NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant…
NEW YORK (Reuters Health) – Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the…
NEW YORK (Reuters Health) – For patients on maintenance prasugrel (Effient) therapy having percutaneous coronary intervention (PCI), a dose of 60 mg in the peri-PCI period achieves “faster…
